SHELL ASSET MANAGEMENT CO - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$81
-2.4%
1,2000.0%0.00%0.0%
Q2 2023$83
-66.3%
1,200
-76.5%
0.00%
-70.0%
Q1 2023$246
-3.5%
5,1000.0%0.01%
-9.1%
Q4 2022$255
-99.8%
5,100
+70.0%
0.01%
+120.0%
Q3 2022$122,000
-70.8%
3,000
-60.5%
0.01%
-58.3%
Q2 2022$418,0007,6000.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$56,230,87217.46%
Paradigm Biocapital Advisors LP 1,805,717$124,648,6459.63%
HHLR ADVISORS, LTD. 6,436,533$444,313,8739.46%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,692$77,568,4599.09%
RA Capital Management 6,264,707$432,452,7248.16%
Tri Locum Partners LP 116,768$8,060,4953.00%
Nicholas Investment Partners, LP 593,167$40,946,3182.80%
E Fund Management (Hong Kong) Co., Ltd. 51,679$3,5672.66%
Avidity Partners Management LP 798,900$55,148,0671.93%
Boxer Capital, LLC 600,000$41,4181.92%
View complete list of LEGEND BIOTECH CORP shareholders